甲状腺機能検査の世界市場規模：検査タイプ別、エンドユーザー別、用途別、地域別、範囲および予測

甲状腺機能検査の市場規模と予測

甲状腺機能検査市場規模は、2024年に19億1,000万米ドルと評価され、2024年から2031年にかけてCAGR 6.10%で成長し、2031年には29億4,000万米ドルに達すると予測されています。

甲状腺機能検査（TFT）は、代謝とホルモン産生を調整する甲状腺の能力を調べる診断ツールです。これらの検査は、血液サンプル中の甲状腺ホルモン（T3およびT4）、甲状腺刺激ホルモン（TSH）およびその他の甲状腺関連指標を検出します。甲状腺機能検査は、甲状腺機能低下症、甲状腺機能亢進症、甲状腺結節などの甲状腺の問題を特定するために不可欠です。

甲状腺機能検査は、甲状腺の健康状態を評価し、甲状腺疾患のある人の薬効を追跡するための臨床診断に用いられます。TFTはまた、早期発見と管理を可能にする先天性甲状腺機能低下症の新生児スクリーニングにも使用されます。

今後、甲状腺機能検査市場は、世界の甲状腺疾患率の上昇、意識向上とスクリーニング活動、検査技術の進歩により、優れた成長見通しを示します。今後の進歩は、検査精度の向上、所要時間の短縮、予測指標やポイントオブケア検査を組み込んだTFTの応用範囲の拡大に集中する可能性があります。ヘルスケアシステムが予防医療と個別化薬物療法を推進するにつれて、包括的な甲状腺機能検査の需要が高まり、市場の成長を後押しする可能性が高いです。

甲状腺機能検査市場力学

主な市場促進要因

甲状腺疾患の発生率の増加：甲状腺機能低下症、甲状腺機能亢進症、甲状腺がんなどの甲状腺疾患の世界の有病率の増加が主な要因です。知識と診断方法の向上に伴い、甲状腺機能障害の検査を受ける人が増え、TFTの需要が増加しています。

診断技術の技術的進歩：TFT市場の拡大は、より高感度で特異的な検査法、自動化された検査プラットフォーム、ポイント・オブ・ケア検査の選択肢といった技術的進歩によって推進されています。これらの進歩は診断精度を向上させ、所要時間を短縮し、医療従事者と患者の利便性を高める。

高齢化とヘルスケア意識：甲状腺疾患に罹患しやすい高齢化人口の増加とヘルスケア意識の向上およびスクリーニングプログラムが、TFT市場の成長に拍車をかけています。甲状腺機能の早期発見と定期的なモニタリングが一般的な処置となり、これらの検査に対する市場の需要を押し上げています。

主な課題：

検査結果と解釈のばらつき：TFTは、薬物、病気、妊娠を含む様々な変数の影響を受ける可能性があり、その結果、検査所見にばらつきが生じる。誤診や不適切な治療を避けるためには、患者の病歴や臨床状況を考慮して、これらのデータを慎重に解釈する必要があります。

コストの制約と償還の問題：TFTとそれに付随する診断手技の費用は、患者やヘルスケアシステムによっては法外に高額な場合があります。様々な検査に対する償還方針と適用範囲の制約は、甲状腺の完全な健康評価を求める臨床医と患者の双方にとって経済的なハードルを生み出しています。

規制とコンプライアンスの課題：TFT市場のメーカーやヘルスケアプロバイダーは、規制要件や進化する診断検査手順の遵守という課題に直面しています。品質基準へのコンプライアンスを確保し、関連認証を取得し、複数の場所で規制変更の交渉を行うことは、リソース集約的で時間のかかる作業となります。

主要動向：

先端検査技術の採用：TFTでは、極めて高感度で特異的なアッセイ、自動化された検査プラットフォーム、分子診断薬の使用が一般的になりつつあります。これらの高度な技術は診断精度を向上させ、所要時間を短縮し、甲状腺機能検査の全体的な効率を高める。

ポイントオブケア検査（POCT）の統合：ポイントオブケア検査が甲状腺機能測定に用いられるようになってきています。POCTは、迅速なその場での検査を可能にし、その結果、即座にデータが得られ、より迅速な臨床的意思決定が可能になります。この動向は、患者の継続的なモニタリングだけでなく、遠隔地や資源の限られた環境において特に有用です。

予防医療と早期診断の重視：予防医療と甲状腺疾患の早期発見がますます重視されるようになってきています。意識向上への努力、定期的なスクリーニングプログラム、積極的な健康診断により、甲状腺機能検査を受ける人が増えています。このような傾向は、甲状腺の問題を早期に発見し治療することで、患者の予後をかなり改善できるという認識から生じています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 甲状腺機能検査市場：検査タイプ別

• 甲状腺刺激ホルモン（TSH）検査
• T4（サイロキシン）検査
• T3（トリヨードサイロニン）検査
• 甲状腺抗体検査

第5章 甲状腺機能検査市場：エンドユーザー別

• 病院
• 診断研究所
• 研究機関

第6章 甲状腺機能検査市場：用途別

• 甲状腺機能低下症
• 甲状腺機能亢進症
• 甲状腺結節
• 甲状腺がん

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Abbott Laboratories
• Siemens Healthineers AG
• Danaher Corporation
• Roche Diagnostics
• Thermo Fisher Scientific
• Meridian Bioscience, Inc.
• Beckman Coulter Inc.
• Omega Diagnostics Group plc
• Bio-Rad Laboratories, Inc.

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Thyroid Function Test Market Size And Forecast

Thyroid Function Test Market size was valued at USD 1.91 Billion in 2024 and is projected to reach USD 2.94 Billion by 2031, growing at a CAGR of 6.10% from 2024 to 2031.

Thyroid function tests (TFTs) are diagnostic tools that examine the thyroid gland's ability to regulate metabolism and hormone production. These tests detect thyroid hormones (T3 and T4), thyroid-stimulating hormone (TSH) and other thyroid-related indicators in blood samples. TFTs are essential for identifying thyroid problems such as hypothyroidism, hyperthyroidism and thyroid nodules.

Thyroid function tests are used in clinical diagnostics to assess thyroid health and track medication efficacy in individuals with thyroid disorders. TFTs are also used to screen neonates for congenital hypothyroidism which allows for early detection and management.

Looking ahead, the thyroid function test market exhibits excellent growth prospects owing to rising rates of thyroid illnesses worldwide, increased awareness and screening activities and advancements in testing technology. Future advancements may concentrate on improving test accuracy shortening turnaround times and broadening the application of TFTs to incorporate predictive indicators or point-of-care testing. As healthcare systems promote preventive care and individualized medication, the demand for comprehensive thyroid function testing is likely to rise fueling market growth.

Thyroid Function Test Market Dynamics

The key market dynamics that are shaping the global thyroid function test market include:

Key Market Drivers:

Increasing Incidence of Thyroid Disorders: The increased global prevalence of thyroid problems such as hypothyroidism, hyperthyroidism and thyroid cancer are the major factors. As knowledge and diagnostic methods improve, more people are being checked for thyroid dysfunction which increases demand for TFTs.

Technological Advances in Diagnostic Technologies: TFT market expansion is being driven by technological advancements such as more sensitive and specific assays, automated testing platforms and point-of-care testing choices. These advancements improve diagnostic accuracy, shorten turnaround times and increase convenience for both healthcare personnel and patients.

Aging Population and Healthcare Awareness: The growing aging population which is more susceptible to thyroid diseases together with increased healthcare awareness and screening programs adds to the TFT market's growth. Early detection and regular monitoring of thyroid function have become common procedures driving up market demand for these tests.

Key Challenges:

Variability in Test Findings and Interpretation: TFTs can be affected by a variety of variables including drugs, sickness and pregnancy resulting in variable test findings. To avoid misdiagnosis or inappropriate therapies, these data must be interpreted carefully taking into account the patient's history and clinical situation.

Cost Constraints and Reimbursement Issues: The cost of TFTs and accompanying diagnostic procedures may be prohibitively expensive for some patients and healthcare systems. Reimbursement policies and coverage constraints for various tests differ creating financial hurdles for both clinicians and patients seeking a full thyroid health assessment.

Regulatory and Compliance Challenges: Manufacturers and healthcare providers in the TFT market face challenges in adhering to regulatory requirements and evolving diagnostic testing procedures. Ensuring compliance with quality standards getting relevant certifications and negotiating regulatory changes across multiple locations can be resource-intensive and time-consuming.

Key Trends:

Adoption of Advanced Testing Technologies: In TFTs, the use of extremely sensitive and specific assays, automated testing platforms and molecular diagnostics is becoming increasingly common. These sophisticated technologies improve diagnostic accuracy shorten turnaround times and increase overall efficiency in thyroid function testing.

Integration of Point-of-Care Testing (POCT): Point-of-care testing is increasingly being used to measure thyroid function. POCT provides for rapid, on-site testing resulting in instant data and faster clinical decision-making. This trend is especially useful in remote or resource-limited environments as well as for continuous patient monitoring.

Focus on Preventive Care and Early Diagnosis: There is an increasing emphasis on preventive care and early detection of thyroid diseases. Increased awareness efforts, regular screening programs and proactive health check-ups are encouraging more people to have their thyroid function tested. This tendency stems from the realization that early detection and treatment of thyroid problems can considerably enhance patient outcomes.

Global Thyroid Function Test Market Regional Analysis

Here is a more detailed regional analysis of the global thyroid function test market:

North America:

According to Verified Market Research analyst, North America is expected to dominate the global thyroid function test market.

The region's dominance is due to the widespread availability of thyroid function tests and the presence of trained healthcare professionals. The region's excellent healthcare infrastructure makes diagnostic facilities accessible and healthcare providers are well-trained to deliver and interpret these tests correctly. This accessibility and knowledge help increase the widespread use and reliability of TFTs, resulting in industry development.

Furthermore, the required screening of newborns for congenital hypothyroidism greatly boosts the market. Early discovery through these screens allows for timely care lowering the risk of developmental difficulties linked with thyroid abnormalities. Furthermore, cost-effective technologies for screening thyroid cancer are driving the market. Affordable and efficient diagnostic solutions promote routine screening and early diagnosis, hence improving patient outcomes and expanding the market. These factors together with a strong emphasis on preventive healthcare position North America as a dominant region in the TFT market over the projection period.

Asia Pacific:

Asia-Pacific is the fastest growing region in the thyroid function test (TFT) market over the forecast period owing to rising thyroid health awareness and the incidence of thyroid illnesses. As public health campaigns and educational initiatives raise awareness about the necessity of thyroid function tests, an increasing number of people seek diagnosis and treatment for thyroid-related diseases. This expanding awareness is critical for early detection and management resulting in increased demand for TFTs throughout the region.

Furthermore, the increased frequency of thyroid illnesses such as hypothyroidism, hyperthyroidism and thyroid cancer is a major driver of market expansion in Asia Pacific. Changing lifestyles, dietary patterns and environmental variables all contribute to an increase in the prevalence of these illnesses. As more individuals suffer from thyroid-related health disorders, the demand for accurate and easily accessible diagnostic tests grows supporting the TFT market's rise.

Furthermore, the introduction of many novel tests for monitoring thyroid levels as well as the widespread adoption of important strategic initiatives are increasing market growth. Diagnostic technology advancements give more precise, reliable and cost-effective testing choices making it easier for healthcare providers to detect and manage thyroid diseases. Strategic partnerships, mergers and collaborations among key healthcare sector companies are also increasing the availability and use of advanced TFTs driving the market's rapid expansion in the Asia-Pacific region.

Global Thyroid Function Test Market: Segmentation Analysis

The Global Thyroid Function Test Market is segmented on the basis of Type of Test, End User, Application, and Geography.

Thyroid Function Test Market, By Type of Test

• Thyroid-Stimulating Hormone (TSH) Tests
• T4 (Thyroxine) Tests
• T3 (Triiodothyronine) Tests
• Thyroid Antibody Tests

Based on Type of Test, the market is Thyroid-Stimulating Hormone (TSH) Tests, T4 (Thyroxine) Tests, T3 (Triiodothyronine) Tests and Thyroid Antibody Tests. Thyroid-Stimulating Hormone (TSH) Tests dominate the thyroid function testing industry. TSH tests are critical for detecting and managing thyroid problems because they give a sensitive and accurate picture of thyroid function. They are frequently the first-line tests recommended by healthcare providers making them the most commonly utilized and necessary in clinical practice.

Thyroid Function Test Market, By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes

Based on End User, the market is divided into Hospitals, Diagnostic Laboratories, and Research Institutes. Thyroid function tests (TFTs) are mostly used by hospitals. Their extensive healthcare offerings, large patient volume and availability of advanced diagnostic facilities all contribute to their supremacy. Hospitals are frequently the principal sites for thyroid problem diagnosis, treatment and management assuring a continual need for TFTs in their everyday clinical processes.

Thyroid Function Test Market, By Application

• Hypothyroidism
• Hyperthyroidism
• Thyroid Nodules
• Thyroid Cancer

Based on Application, the market is segmented into Hypothyroidism, Hyperthyroidism, Thyroid Nodules and Thyroid Cancer. Hypothyroidism is the most common application in the thyroid function testing (TFT) market. This dominance is due to its widespread occurrence as well as the need for ongoing monitoring and treatment. Hypothyroidism necessitates frequent TFTs to properly adapt and manage treatment resulting in a continual demand for these tests in clinical settings.

Thyroid Function Test Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Thyroid Function Test Market is classified into North America, Europe, Asia Pacific and the Rest of the world. North America dominates the global thyroid function test (TFT) market due to broad test availability, competent healthcare providers, mandated newborn screening and low-cost cancer diagnostics. Meanwhile, Asia-Pacific is the fastest-growing region due to increased awareness, higher thyroid problem prevalence and advances in diagnostic tools. Strategic actions and public health campaigns drive up demand for TFTs in the Asia Pacific region.

Key Players

• The Global Thyroid Function Test study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Roche Diagnostics, Thermo Fisher Scientific, Meridian Bioscience Inc., Beckman Coulter Inc., Omega Diagnostics Group plc and Bio-Rad Laboratories Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

• Thyroid Function Test Market Recent Developments
• In February 2021, Abbott Laboratories and Roche Diagnostics recently made waves with a research comparing their thyroid tests for subclinical hypothyroidism. The study discovered that Roche's free thyroxine and TSH assays produced much higher diagnostic results for subclinical hypothyroidism (SCH) than Abbott's thyroid assays.
• In May 2020, Eli Lilly and Company received approval from the U.S. Food and Drug Administration (FDA) for Retevmo, a treatment for Advanced or metastatic RET fusion-positive thyroid cancer, Advanced or metastatic RET-mutant medullary thyroid cancer (MTC) and Metastatic RET fusion-positive non-small cell lung cancer (NSCLC).

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Thyroid Function Test Market, By Type of Test

• Thyroid-Stimulating Hormone (TSH) Tests
• T4 (Thyroxine) Tests
• T3 (Triiodothyronine) Tests
• Thyroid Antibody Tests

5. Thyroid Function Test Market, By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes

6. Thyroid Function Test Market, By Application

• Hypothyroidism
• Hyperthyroidism
• Thyroid Nodules
• Thyroid Cancer

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Laboratories
• Siemens Healthineers AG
• Danaher Corporation
• Roche Diagnostics
• Thermo Fisher Scientific
• Meridian Bioscience, Inc.
• Beckman Coulter Inc.
• Omega Diagnostics Group plc
• Bio-Rad Laboratories, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References